Drugs / LNG/EE
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06783192 | Aug → Oct 2023 | HIV infectious disease | Merck Sharp & Dohme LLC | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LNG/EE | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06783192 ↗ |
| Route | Oral | “LNG/EE combination tablet taken by mouth.” NCT06783192 ↗ |